Elbit Systems Q3 Profit Climbs, Beats Market, But Revenues Miss

Elbit Systems reported Q3 adjusted EPS of $3.35 ($159.8m adjusted net) and GAAP EPS of $2.80 ($133.4m), beating the Street EPS of $2.73, while revenue rose to $1.92bn from $1.72bn year‑over‑year but missed consensus of $1.99bn. Segment performance was mixed—Aerospace down 3%, C4I & Cyber up 14%, ISTAR & EW up 5% and Land up 41%—with Elbit Systems of America revenues down 2%. The company’s order backlog grew to $25.2bn (about 69% outside Israel and ~38% slated for 2025–26), the board declared a $0.75/share dividend, and Elbit disclosed a new roughly $2.3bn eight‑year international contract; shares rose about 4% to $522.82 on the news.

Analysis

Elbit Systems reported Q3 GAAP net income attributable to shareholders of $133.4 million ($2.80/share) versus $79.11 million ($1.77/share) a year earlier, and adjusted net income of $159.8 million ($3.35/share) versus $98.8 million ($2.21/share). Adjusted EPS beat the Street at $2.73 while revenue rose 11.6% year‑over‑year to $1.92 billion but missed consensus of $1.99 billion; shares rose roughly 4% to $522.82 in overnight trading.

Operational performance was mixed: Aerospace revenue declined 3%, Elbit Systems of America fell 2% (driven by electronic systems and medical instrumentation), while C4I & Cyber grew 14%, ISTAR & EW grew 5% and Land jumped 41%. The order backlog increased to $25.2 billion driven mainly by new European orders, with about 69% of backlog outside Israel and roughly 38% scheduled for 2025–26, indicating multi‑year visibility but geographic concentration.

The board declared a $0.75/share dividend (record Dec 22, pay Jan 5, 2026) and disclosed an approximately $2.3 billion eight‑year international contract, improving forward revenue visibility. Key risks are near‑term revenue conversion and execution on large international awards given the revenue miss and U.S. subsidiary weakness; adjusted versus GAAP differences suggest investors should watch special items and margins in coming quarters.

Key Decisions for Investors

• Consider adding to positions on modest pullbacks given the adjusted EPS beat ($3.35 vs $2.73) and a $25.2bn backlog plus a ~$2.3bn eight‑year contract, which support medium‑term cash flow
• Monitor top‑line momentum and segment trends closely—if Aerospace and Elbit Systems of America revenues continue to lag, be prepared to trim exposure or reassess valuation
• Incorporate the $0.75 dividend into a total‑return assessment but quantify execution and geographic risk from 69% of backlog outside Israel and only ~38% scheduled for 2025–26
• Use hedges or defined stop levels ahead of the next quarter if management fails to demonstrate revenue conversion and margin sustainability given the revenue miss versus consensus